Dobrocky, Tomas http://orcid.org/0000-0002-6167-3343
Kaesmacher, Johannes
Bellwald, Sebastian
Piechowiak, Eike
Mosimann, Pascal J.
Zibold, Felix
Jung, Simon
Arnold, Marcel
Fischer, Urs
Gralla, Jan
Mordasini, Pasquale
Article History
Received: 8 November 2018
Accepted: 16 February 2019
First Online: 11 March 2019
Compliance with Ethical Standards
:
: Unrelated: Dr Gralla reports acting as a global principal investigator of the STAR study; a clinical events committee member of the PROMISE study (Penumbra); and the principal investigator for the SWIFT DIRECT study (Medtronic). Dr Gralla also reports serving as a consultant for Medtronic and receiving Swiss National Science Foundation grants for magnetic resonance imaging in stroke. Professor Fischer is a global PI for the SWIFT DIRECT study (Medtronic) and receives research grants from SNSF. Professor Arnold has received speaker honoraria from Bayer, Boehringer Ingelheim, and Covidien, and scientific advisory board honoraria from Bayer, Boehringer Ingelheim, BMS, Pfizer, Covidien, Daichy Sankyo, and Nestlé Health Science. Dr Mosimann receives research grants from SNSF to study new therapeutic options for cerebral aneurysms. Mr Kaesmacher receives research grants from the Swiss Stroke Society and the Bangerter Foundation. All other authors have nothing to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: This study has obtained IRB approval from (indicate the relevant board), and the need for informed consent was waived. The registry was approved by the local ethics committee (Kantonale Ethikkommission für die Forschung Bern, Bern, Switzerland, Amendment Access Number: 231/2014).